Unibest 优贝德
← Back to patent-cliff list

CAS 99-33-2

3,5-dinitrobenzoyl chloride3,5-Dinitrobenzoyl chloride

CodesCANN-003、(VIII)140605-16-a

Application context (from source-drug indications)

结节性脑硬化大麻二酚Dravet综合征大麻二酚Lennox Gastaut综合征大麻二酚精神病大麻二酚Ⅲ型黏多糖贮积症大麻二酚系统性硬皮病大麻二酚膀胱癌多西他赛纳米胶束 (Samyang Biopharmaceuticals)头颈癌多西他赛纳米胶束 (Samyang Biopharmaceuticals)头颈部鳞状细胞癌多西他赛纳米胶束 (Samyang Biopharmaceuticals)实体瘤多西他赛纳米胶束 (Samyang Biopharmaceuticals)

Source drugs (routes using this intermediate)

DrugTierExpiry
大麻二酚CannabidiolTier B — Position early-
多西他赛纳米胶束 (Samyang Biopharmaceuticals)Docetaxel polymeric micelle (Samyang Biopharmaceuticals)Tier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

大麻二酚原研路线steps: 3total yield: 17.00-19.00 g
(1'R,2'R)-2,6-dihydroxy-5'-methyl-4-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro-[1,1'-biphenyl]-3-carboxylic acid(1'R,2'R)-5'-methyl-4-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro-[1,1'-biphenyl]-2,6-diol3,5-dinitrobenzoyl chloride(1'R,2'R)-5'-methyl-4-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro-[1,1'-biphenyl]-2,6-diyl bis(3,5-dinitrobenzoate)

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.